SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004237
Filing Date
2021-11-12
Accepted
2021-11-12 07:31:02
Documents
45
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hcwb-20210930.htm   iXBRL 10-Q 2190896
2 EX-31.1 hcwb-ex31_1.htm EX-31.1 15591
3 EX-31.2 hcwb-ex31_2.htm EX-31.2 15857
4 EX-32.1 hcwb-ex32_1.htm EX-32.1 11553
5 EX-32.2 hcwb-ex32_2.htm EX-32.2 11232
  Complete submission text file 0000950170-21-004237.txt   5250344

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hcwb-20210930_lab.xml EX-101.LAB 239639
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hcwb-20210930_def.xml EX-101.DEF 138953
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hcwb-20210930.xsd EX-101.SCH 27257
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hcwb-20210930_pre.xml EX-101.PRE 188749
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hcwb-20210930_cal.xml EX-101.CAL 22315
11 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20210930_htm.xml XML 650096
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 211399585
SIC: 2834 Pharmaceutical Preparations